Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.48 +0.09 (+2.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Neuphoria Therapeutics (NEUP) Short-term Investments (2021)

Updated

Neuphoria Therapeutics (NEUP) recorded Short-term Investments of $335,467 in fiscal Q4 2021 (quarter ended Jun 30, 2021).

Analysis

Neuphoria Therapeutics (NEUP) Short-term Investments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn
10 Neuphoria Therapeutics 422.60 Mn 347.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 327,322.47
API Access

Neuphoria Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=NEUP&period=max&api_key=YOUR_API_KEY